AU2002226690A1 - Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases - Google Patents
Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseasesInfo
- Publication number
- AU2002226690A1 AU2002226690A1 AU2002226690A AU2002226690A AU2002226690A1 AU 2002226690 A1 AU2002226690 A1 AU 2002226690A1 AU 2002226690 A AU2002226690 A AU 2002226690A AU 2002226690 A AU2002226690 A AU 2002226690A AU 2002226690 A1 AU2002226690 A1 AU 2002226690A1
- Authority
- AU
- Australia
- Prior art keywords
- diagnosis
- drugs
- tissue
- treatment
- proliferative diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001014954 | 2001-01-23 | ||
| JP2001-14954 | 2001-01-23 | ||
| PCT/JP2002/000408 WO2002058740A1 (en) | 2001-01-23 | 2002-01-22 | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002226690A1 true AU2002226690A1 (en) | 2003-02-06 |
| AU2002226690B2 AU2002226690B2 (en) | 2006-07-13 |
Family
ID=18881578
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002226690A Ceased AU2002226690B2 (en) | 2001-01-23 | 2002-01-22 | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7045115B2 (en) |
| EP (1) | EP1270017B1 (en) |
| JP (1) | JP4210118B2 (en) |
| KR (1) | KR100867729B1 (en) |
| CN (1) | CN100400107C (en) |
| AT (1) | ATE322912T1 (en) |
| AU (1) | AU2002226690B2 (en) |
| CA (1) | CA2402991C (en) |
| DE (1) | DE60210538T2 (en) |
| NO (1) | NO328812B1 (en) |
| NZ (1) | NZ520934A (en) |
| TW (1) | TWI247609B (en) |
| WO (1) | WO2002058740A1 (en) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
| EP1673353A4 (en) * | 2003-09-05 | 2007-03-28 | Einstein Coll Med | TRANSITION STATE STRUCTURE AND INHIBITORS OF THYMIDINE PHOSPHORYLASES |
| CA2538252C (en) * | 2003-09-18 | 2014-02-25 | Isis Pharmaceuticals, Inc. | 4'-thionucleosides and oligomeric compounds |
| US7485283B2 (en) * | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
| JP4841231B2 (en) * | 2005-11-07 | 2011-12-21 | 日本メジフィジックス株式会社 | Tissue proliferative diagnostic agent |
| US20070274908A1 (en) * | 2006-04-07 | 2007-11-29 | The Board Of Regents Of The University Of Texas System | Methods and compositions related to adenoassociated virus-phage particles |
| US7928210B2 (en) | 2007-03-01 | 2011-04-19 | Siemens Medical Solutions Usa, Inc. | Nucleoside based proliferation imaging markers |
| WO2008124197A1 (en) * | 2007-04-10 | 2008-10-16 | The Johns Hopkins University | Imaging and therapy of virus-associated tumors |
| JP5946992B2 (en) * | 2008-02-29 | 2016-07-06 | ランセウス メディカル イメージング, インコーポレイテッド | Contrast agents for applications involving perfusion imaging |
| GB0815831D0 (en) * | 2008-09-01 | 2008-10-08 | Imp Innovations Ltd | Compounds |
| DK2419096T3 (en) | 2009-04-15 | 2020-02-03 | Lantheus Medical Imaging Inc | STABILIZATION OF RADIOPHARMACEUTICAL COMPOSITIONS USING ASCORBIC ACID |
| CA2789044C (en) | 2010-02-08 | 2020-09-15 | Lantheus Medical Imaging, Inc. | Methods and apparatus for synthesizing imaging agents, and intermediates thereof |
| US8835612B2 (en) * | 2010-10-09 | 2014-09-16 | Fabio Polato | Isolation of phosphoproteins, glycoproteins and fragments thereof |
| JP5794521B2 (en) * | 2011-03-29 | 2015-10-14 | 国立大学法人福井大学 | Apoptosis inducer |
| BR112014020416B1 (en) | 2012-03-28 | 2022-03-29 | Fujifilm Corporation | 1-(2-deoxy-2-fluor-4-thio-ß-darabinofuranosyl) cytosine crystal and pharmaceutical composition containing said crystal |
| AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
| TWI603966B (en) | 2012-08-13 | 2017-11-01 | 富士軟片股份有限公司 | Synthesis intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl) cytosine, synthesis intermediate of thionucleoside and manufacturing method thereof |
| JP2014062054A (en) * | 2012-09-20 | 2014-04-10 | Gyoseiin Genshino Iinkai Kakuno Kenkyusho | Probe of iodine-123 marker thymine analogue [123i]-iarau |
| JP6351107B2 (en) * | 2014-02-18 | 2018-07-04 | 富士フイルム株式会社 | Method for producing thiolane skeleton type sugar compound and thiolane skeleton type sugar compound |
| TWI678373B (en) | 2014-10-31 | 2019-12-01 | 日商富士軟片股份有限公司 | Thionucleoside derivative or its salt and pharmaceutical composition |
| MX392665B (en) | 2016-08-31 | 2025-03-24 | Fujifilm Corp | ANTITUMORAL AGENT, ANTITUMORAL EFFECT ENHANCER, AND ANTITUMORAL KIT. |
| MX2018002611A (en) | 2018-01-29 | 2019-07-30 | Fujifilm Corp | Antitumor agent for biliary cancer and treatment method of biliary cancer. |
| CN113683648B (en) * | 2021-08-26 | 2025-03-07 | 上海皓鸿生物医药科技有限公司 | A synthetic method of 2'-fluoro-2'-deoxyuridine and its intermediate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE74701B1 (en) * | 1989-10-04 | 1997-07-30 | Univ Birmingham | Further antiviral pyrimidine nucleosides |
| US5077034A (en) * | 1990-03-30 | 1991-12-31 | The President And Fellows Of Harvard College | Treatment of tumors with 5-radioiodo-2'-deoxyuridine |
| US5248771A (en) * | 1991-06-26 | 1993-09-28 | Triumf | Process for preparing no-carrier-added radiohalogenated vinyl nucleosides |
| GB9421223D0 (en) | 1994-10-21 | 1994-12-07 | Univ Alberta | Tissue imaging in gene therapy |
| US5574148A (en) | 1995-02-02 | 1996-11-12 | President U Fellows Of Harvard College | Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides |
| US5703056A (en) | 1995-03-15 | 1997-12-30 | Sloan-Kettering Institute For Cancer Research | Non-invasive imaging of gene transfer |
| US5720935A (en) * | 1995-06-09 | 1998-02-24 | President & Fellows Of Harvard College | Rapid synthesis of radiolabeled pyrimidine nucleosides or nucleotides from stannyl precursors |
| WO1996041646A2 (en) | 1995-06-13 | 1996-12-27 | Dyer, Alison, Margaret | Pharmaceutical compositions containing lornoxicam and cyclodextrin |
| US6331287B1 (en) | 1995-08-23 | 2001-12-18 | University Advanced Bio-Imaging Associates | 2′-deoxy-2′-fluoro-d-arabinofuranosyl pyrimidine nucleoside |
| WO2001005439A1 (en) * | 1999-07-14 | 2001-01-25 | President And Fellows Of Harvard College | Radiodetection and therapy of aberrant cell proliferation |
| KR200188038Y1 (en) | 2000-01-24 | 2000-07-15 | 이정진 | Hand phone for electron pulse |
-
2002
- 2002-01-18 TW TW091100830A patent/TWI247609B/en not_active IP Right Cessation
- 2002-01-22 JP JP2002559074A patent/JP4210118B2/en not_active Expired - Lifetime
- 2002-01-22 DE DE60210538T patent/DE60210538T2/en not_active Expired - Lifetime
- 2002-01-22 KR KR1020027012275A patent/KR100867729B1/en not_active Expired - Fee Related
- 2002-01-22 NZ NZ52093402A patent/NZ520934A/en not_active IP Right Cessation
- 2002-01-22 CN CNB028001540A patent/CN100400107C/en not_active Expired - Fee Related
- 2002-01-22 US US10/239,355 patent/US7045115B2/en not_active Expired - Lifetime
- 2002-01-22 AU AU2002226690A patent/AU2002226690B2/en not_active Ceased
- 2002-01-22 WO PCT/JP2002/000408 patent/WO2002058740A1/en not_active Ceased
- 2002-01-22 EP EP02716326A patent/EP1270017B1/en not_active Expired - Lifetime
- 2002-01-22 AT AT02716326T patent/ATE322912T1/en not_active IP Right Cessation
- 2002-01-22 CA CA002402991A patent/CA2402991C/en not_active Expired - Fee Related
- 2002-09-10 NO NO20024324A patent/NO328812B1/en not_active IP Right Cessation
-
2004
- 2004-11-16 US US10/988,657 patent/US7118731B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002226690A1 (en) | Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases | |
| AU2003291992A1 (en) | Phenylethanolamine derivatives for the treatment of respiratory diseases | |
| AU2002252373A1 (en) | Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders | |
| WO2002086502A8 (en) | Methods for the diagnosis and treatment of bone disorders | |
| AU2003239531A1 (en) | Protein cages for the delivery of medical imaging and therapy | |
| AU2003300791A1 (en) | Combination therapy for the treatment of pain | |
| AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
| PT1487828E (en) | Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases | |
| AU2002312897A1 (en) | Drugs for the treatment of the alzheimer disease | |
| AU2003263628A1 (en) | Medical treatment system for stimulating spots on the body suitable for acupuncture | |
| AU2003299378A1 (en) | Method and compounds for inhibiting hec1 activity for the treatment of proliferative diseases | |
| AU2003291536A1 (en) | Method for the diagnosis and treatment of vascular disease | |
| AU2003209150A1 (en) | Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases | |
| AU2003246592A1 (en) | Tumour marker and the use thereof for the diagnosis and treatment of tumour diseases | |
| AU2002227895A1 (en) | Sulphonamides for the treatment of central nervous system diseases | |
| AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
| HUP0103017A3 (en) | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use | |
| AU2002246151A1 (en) | Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases | |
| AU5611701A (en) | Agent for the diagnosis and therapy of viral diseases | |
| AU2003263036A1 (en) | SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
| AU2002249891A1 (en) | Compounds and methods for the diagnosis and treatment of babesia infection | |
| GB0212790D0 (en) | Medicament for the treatment of diabetes | |
| AU2002344959A1 (en) | Use of fasl for the treatment of neurodegenerative diseases | |
| AU2002365654A1 (en) | Treatment of diseases via the skin | |
| AU2002350513A1 (en) | Use of solasonine for the treatment of skin tumors |